Clinical Trial: A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Eosinophilic Gastritis
Study Type: INTERVENTIONAL
Official Title: A Phase 2/3, Randomized, 3-Part Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis
Brief Summary:
The study is researching an experimental drug called dupilumab.The study is focused on participants with active eosinophilic gastritis (EoG) with or without eosinophilic duodenitis (EoD).Participants with EoD only are not eligible for enrollment.EoG and EoD are uncommon, persistent, allergic/immune diseases in which eosinophils (a type of white blood cell) gather in large numbers in the stomach and small intestine and cause inflammation and damage.The aim of the study is to evaluate the effect of dupilumab on…
Read more